Surgery Partners Q2 Revenue Climbs 2.7%, Net Loss Deepens; $795M Hospital Sale Announced
SGRY sits 40% above its 52-week low of $11.41 on elevated volume (2.7× avg).
Summary
Surgery Partners reported mixed Q2 2026 results with revenue growth but widening losses, and separately announced a $795 million hospital sale that could transform its financial position.
Key Events · Earnings and Guidance · SGRY
-
Q2 Revenue Up, Losses Widen
Revenue rose 2.7% to $848.9M, but net loss attributable to Surgery Partners grew to $15.0M from $2.5M a year ago. Adjusted EBITDA fell 2.9% to $125.2M.
-
$795M Hospital Sale Announced
Subsequent to quarter-end, the company entered definitive agreements to sell two hospitals for total consideration of approximately $795 million, including proportionate debt. Proceeds are subject to adjustments and closing conditions.
-
Share Repurchase Authorization
Board authorized a $200M share repurchase program in February 2026, but no shares were repurchased during Q2.
-
Valuation Allowance on Deferred Tax Assets
Full valuation allowance recorded against net deferred tax assets due to a cumulative three-year pre-tax loss position, signaling uncertainty around future taxable income.
Analysis · SGRY · Industrial Applications And Services
Surgery Partners posted Q2 revenue of $848.9 million, a 2.7% increase year-over-year, but net loss attributable to the company widened to $15.0 million from $2.5 million a year ago. Adjusted EBITDA slipped 2.9% to $125.2 million. The quarter's results were overshadowed by a subsequent event: a definitive agreement to sell two hospitals for approximately $795 million in total consideration, a significant portfolio move that could reshape the balance sheet. The company also disclosed a $200 million share repurchase authorization, though no buybacks occurred in Q2. A full valuation allowance on deferred tax assets reflects persistent pre-tax losses, a red flag for future earnings power.
At the time of this filing, SGRY was trading at $15.95 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $11.41 to $24.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.